U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271576) titled 'Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis' on Nov. 17.
Brief Summary: This clinical trial aims to determine whether phycocyanin, a natural protein derived from spirulina, can help treat liver fibrosis or cirrhosis in adult patients. The main questions it aims to answer are:
* Can phycocyanin reduce blood levels of liver enzymes (such as ALT and AST) that indicate liver damage?
* Can phycocyanin improve liver stiffness as measured by ultrasound?
Researchers will compare the phycocyanin intervention group with a control group that receives a placebo (a similar-looking maltodextrin supple...